Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tasimelteon

EU orphan designation number: EU/3/10/841   
Active ingredient: Tasimelteon
Indication: Treatment of non-24-hour sleep-wake disorders in blind people with no light perception
Sponsor: Vanda Pharmaceuticals Limited
222 Regent Street, London W1B 5TR, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Orphan Designation EMA/OD/102/10 (2011)1307 of 23/02/2011
24/11/2014 Change of address of sponsor